Literature DB >> 6975313

Inhibition of lectin-induced lymphocyte activation by 2-cyclohexene-1-one: decreased intracellular glutathione inhibits an early event in the activation sequence.

C M Fischman, M C Udey, M Kurtz, H J Wedner.   

Abstract

The importance of normal intracellular glutathione (GSH) levels in the activation of human peripheral blood lymphocytes (PBL) by mitogenic lectins was explored using 2-cyclohexene-1-one (2-CHX-1), an agent that selectively decreases the levels of intracellular GSH. PBL incubated with mitogenic lectins and graded doses of 2-CHX-1 showed a dose-dependent inhibition of activation assayed by [3H]-thymidine uptake and percentage of blast transformation. 2.5 x 10(-5) M 2-CHX-1, a concentration that decreases GSH levels to less than 20% of control, caused an 80 to 90% suppression of both [3H]-thymidine uptake and blast transformation; lower concentrations were less effective. Time course studies showed that 2-CHX-1 was maximally effective only if added during the first 4 hr of culture. At the concentrations used, 2-CHX-1 was not cytotoxic to lectin-stimulated or unstimulated PBL and did not interfere with mitogen-lymphocyte interaction. These results suggest that adequate levels of glutathione are necessary for lymphocyte activation and that the glutathione requirement is exerted in the early activation sequence.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6975313

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  In Utero Exposure to Histological Chorioamnionitis Primes the Exometabolomic Profiles of Preterm CD4+ T Lymphocytes.

Authors:  Poojitha Matta; Stacy D Sherrod; Christina C Marasco; Daniel J Moore; John A McLean; Joern-Hendrik Weitkamp
Journal:  J Immunol       Date:  2017-09-25       Impact factor: 5.422

Review 2.  Biochemical events associated with lymphocyte activation.

Authors:  H J Wedner
Journal:  Surv Immunol Res       Date:  1984

3.  Augmentation of glutathione in the fluid lining the epithelium of the lower respiratory tract by directly administering glutathione aerosol.

Authors:  R Buhl; C Vogelmeier; M Critenden; R C Hubbard; R F Hoyt; E M Wilson; A M Cantin; R G Crystal
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

4.  Buthionine sulfoximine induced growth inhibition in human lung carcinoma cells does not correlate with glutathione depletion.

Authors:  Y J Kang; D Emery; M D Enger
Journal:  Cell Biol Toxicol       Date:  1991-07       Impact factor: 6.691

5.  Comparative study of intracellular glutathione content in rat lymphocyte cultures treated with 2-mercaptoethanol and interleukin-2.

Authors:  A Aidoo; L E Lyn-Cook; S M Morris; R L Kodell; D A Casciano
Journal:  Cell Biol Toxicol       Date:  1991-07       Impact factor: 6.691

6.  Mercaptoethanol protects glutathione depleted cells.

Authors:  P C Chen; E Gaetjens; J D Broome
Journal:  Agents Actions       Date:  1987-10

7.  Prostaglandin E2 suppresses phytohemagglutinin-induced immune responses of normal human mononuclear cells by decreasing intracellular glutathione generation, but not due to increased DNA strand breaks or apoptosis.

Authors:  C L Yu; C L Liu; C Y Tsai; K H Sun; T S Liao; W M Lin; H L Chen; H S Yu
Journal:  Agents Actions       Date:  1993-11

8.  Inhibition of cell-mediated cytotoxicity by 2-cyclohexene-1-one: evidence for a role for glutathione and/or glutathione-protein interactions in cytolysis.

Authors:  R P MacDermott; M J Bertovich; M J Bragdon; G S Nash; M S Leusch; H J Wedner
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

9.  Glutathione and lymphocyte activation: a function of ageing and auto-immune disease.

Authors:  R K Fidelus; M F Tsan
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

10.  Relationship between 1-chloro-2,4-dinitrobenzene-induced cytoskeletal perturbations and cellular glutathione.

Authors:  M F Leung; I N Chou
Journal:  Cell Biol Toxicol       Date:  1989-01       Impact factor: 6.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.